Reviva Pharmaceuticals Holdings, Inc. (RVPH)
0.3676
+0.03
(+8.12%)
USD |
OTCM |
Nov 06, 16:00
Reviva Pharmaceuticals Holdings EPS Diluted (Quarterly) : -0.1853 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1853 |
| March 31, 2026 | -0.4551 |
| December 31, 2025 | -0.5734 |
| September 30, 2025 | -1.104 |
| June 30, 2025 | -2.429 |
| March 31, 2025 | -2.645 |
| December 31, 2024 | -2.994 |
| September 30, 2024 | -0.2475 |
| June 30, 2024 | -0.2572 |
| March 31, 2024 | -0.2487 |
| December 31, 2023 | -0.3529 |
| September 30, 2023 | -9.60 |
| June 30, 2023 | -10.44 |
| March 31, 2023 | -6.276 |
| December 31, 2022 | -0.397 |
| Date | Value |
|---|---|
| September 30, 2022 | -0.1824 |
| June 30, 2022 | -0.2892 |
| March 31, 2022 | -0.3988 |
| December 31, 2021 | -0.2553 |
| September 30, 2021 | -0.1235 |
| June 30, 2021 | -0.1249 |
| March 31, 2021 | -0.1028 |
| February 29, 2020 | -0.0172 |
| November 30, 2019 | 0.0524 |
| August 31, 2019 | 0.1053 |
| May 31, 2019 | 0.13 |
| February 28, 2019 | 0.0371 |
| November 30, 2018 | 0.1014 |
| August 31, 2018 | 0.0121 |
| May 31, 2018 | -0.0097 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.448M |
| Total Expenses (Quarterly) | 2.448M |
| Enterprise Value | -14.93M |
| Earnings Yield | -630.4% |
| Normalized Earnings Yield | -630.41 |